Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_assertion type Assertion NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_head.
- NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_assertion description "[Since transgenic overexpression of Fra-2 causes not only fibrosis but also vascular disease, Fra-2 might be an interesting novel candidate for molecular-targeted therapies for SSc.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_provenance.
- NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_assertion evidence source_evidence_literature NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_provenance.
- NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_assertion SIO_000772 20039427 NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_provenance.
- NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_assertion wasDerivedFrom befree-20140225 NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_provenance.
- NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_assertion wasGeneratedBy ECO_0000203 NP615770.RAtjL2UJDwfUzjvTH01CzUPJ1oBPceZSD-Or6u13feogU130_provenance.